[go: up one dir, main page]

AU2002361516A1 - Ophthalmic rofecoxib suspension for the treatment of ocular pain and inflammation - Google Patents

Ophthalmic rofecoxib suspension for the treatment of ocular pain and inflammation

Info

Publication number
AU2002361516A1
AU2002361516A1 AU2002361516A AU2002361516A AU2002361516A1 AU 2002361516 A1 AU2002361516 A1 AU 2002361516A1 AU 2002361516 A AU2002361516 A AU 2002361516A AU 2002361516 A AU2002361516 A AU 2002361516A AU 2002361516 A1 AU2002361516 A1 AU 2002361516A1
Authority
AU
Australia
Prior art keywords
rofecoxib
ophthalmic
inflammation
suspension
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002361516A
Inventor
Arturo Jimenez Bayardo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002361516A1 publication Critical patent/AU2002361516A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002361516A 2001-12-18 2002-12-17 Ophthalmic rofecoxib suspension for the treatment of ocular pain and inflammation Abandoned AU2002361516A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
MXPA01013257A MXPA01013257A (en) 2001-12-18 2001-12-18 Rofecoxib ophthalmic suspension for the treatment of ocular inflammation and pain.
MX01013257 2001-12-18
PCT/MX2002/000116 WO2003051351A1 (en) 2001-12-18 2002-12-17 Ophthalmic rofecoxib suspension for the treatment of ocular pain and inflammation

Publications (1)

Publication Number Publication Date
AU2002361516A1 true AU2002361516A1 (en) 2003-06-30

Family

ID=34056964

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002361516A Abandoned AU2002361516A1 (en) 2001-12-18 2002-12-17 Ophthalmic rofecoxib suspension for the treatment of ocular pain and inflammation

Country Status (3)

Country Link
AU (1) AU2002361516A1 (en)
MX (1) MXPA01013257A (en)
WO (1) WO2003051351A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070114727A (en) 2005-01-28 2007-12-04 갈렌바이오 인코포레이티드 Immunologically active compositions
ES2667945T3 (en) 2007-10-08 2018-05-16 Aurinia Pharmaceuticals Inc. Ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors
MX338355B (en) 2009-06-09 2016-04-13 Aurinia Pharmaceuticals Inc Topical drug delivery systems for ophthalmic use.
RU2421193C2 (en) * 2009-12-07 2011-06-20 Мария Александровна Ковалевская Method of selecting therapy of chronic inflammatory diseases of eye surface based on controlled potentiation of exudative reaction by means of mechanical or immune impact
RU2533274C1 (en) * 2013-12-25 2014-11-20 Илья Александрович Марков Jelly pharmaceutical composition for treating demodectic blepharitis and blepharoconjunctivitis
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2332271C (en) * 1998-05-15 2008-08-05 Wakamoto Pharmaceutical Co., Ltd. Selective cyclooxygenase-2 anti-inflammatory eye drops
SE9803761D0 (en) * 1998-11-04 1998-11-04 Synphora Ab Method to avoid increased iridial pigmentation during prostaglandin treatment
SE0002211D0 (en) * 2000-06-13 2000-06-13 Synphora Ab Methods and compositions for prevention of myopia
PE20020146A1 (en) * 2000-07-13 2002-03-31 Upjohn Co OPHTHALMIC FORMULATION INCLUDING A CYCLOOXYGENASE-2 (COX-2) INHIBITOR
AU5754701A (en) * 2000-07-13 2002-01-30 Pharmacia Corp Method of using cox-2 inhibitors in the treatment and prevention of ocular cox-2mediated disorders
PE20020578A1 (en) * 2000-10-10 2002-08-14 Upjohn Co A TOPICAL ANTIBIOTIC COMPOSITION FOR THE TREATMENT OF EYE INFECTIONS

Also Published As

Publication number Publication date
MXPA01013257A (en) 2003-06-25
WO2003051351A1 (en) 2003-06-26

Similar Documents

Publication Publication Date Title
EP1592435A4 (en) Ophthalmic formulation for the prevention and treatment of ocular conditions
WO2002086502A8 (en) Methods for the diagnosis and treatment of bone disorders
EP1392292A4 (en) Pyranoindazoles and their use for the treatment of glaucoma
AU2002334870B8 (en) Combinations for the treatment of immunoinflammatory disorders
PL352229A1 (en) Prosthesis of sclera for treatment of presbyopia and other sight disorders
AU2002307430A1 (en) Method and system for photodisruption of tissue of the eye
HUP0401605A3 (en) Integrin inhibitors for the treatment of eye diseases
AU2002240463A1 (en) Use of endostatin in the treatment of ocular neovascularization
AU2001256855A1 (en) Preparation for the prevention and treatment of ocular disorders
AUPQ622600A0 (en) Treatment and/or prevention of ocular pain
AU2001259085A1 (en) Treatment of ocular neovascularization and related diseases
AU2002227935A1 (en) Optical stimulation of the human eye
AU2003291253A1 (en) Scleral implants for treatment of eye disorders
AU7106300A (en) Treatment of skin disorders
AU2002361516A1 (en) Ophthalmic rofecoxib suspension for the treatment of ocular pain and inflammation
EP1455780A4 (en) Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
AR026062A1 (en) TREATMENT OF EYE DISORDERS
AU2002246117A1 (en) Method for treatment and diagnosis of eye tissues
IL152782A0 (en) S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders
AU2002240745A1 (en) Diagnosis and treatment of blood disorders
AU2003251734A1 (en) Nicergoline, mmdl and mdl for the treatment of neurodegenerative disorders of the retina and optic nerve
AUPQ330599A0 (en) Novel agents for treatment and diagnosis of ocular disorders
AU2001279720A1 (en) Agent for the external treatment of pain and skin disorders
AU2002365654A1 (en) Treatment of diseases via the skin
HK1064946A (en) Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase